165 related articles for article (PubMed ID: 38516269)
21. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma.
Pan C; Wang Y; Liu Q; Hu Y; Fu J; Xie X; Zhang S; Xi M; Wen J
Oncoimmunology; 2021 Feb; 10(1):1883890. PubMed ID: 33628625
[TBL] [Abstract][Full Text] [Related]
23. PES1 reduces CD8
Ma N; Hua R; Yang Y; Liu ZC; Pan J; Yu BY; Sun YF; Xie D; Wang Y; Li ZG
J Biomed Sci; 2023 Mar; 30(1):20. PubMed ID: 36959575
[TBL] [Abstract][Full Text] [Related]
24. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
Cui G; Li Z; Ren J; Yuan A
Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
[TBL] [Abstract][Full Text] [Related]
25. Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC.
Deng T; Wang H; Yang C; Zuo M; Ji Z; Bai M; Ning T; Liu R; Wang J; Ge S; Zhang L; Ba Y; Zhang H
Front Immunol; 2022; 13():1004345. PubMed ID: 36466860
[TBL] [Abstract][Full Text] [Related]
26. Progenitor-like exhausted SPRY1
Liu Z; Zhang Y; Ma N; Yang Y; Ma Y; Wang F; Wang Y; Wei J; Chen H; Tartarone A; Velotta JB; Dayyani F; Gabriel E; Wakefield CJ; Kidane B; Carbonelli C; Long L; Liu Z; Su J; Li Z
Cancer Cell; 2023 Nov; 41(11):1852-1870.e9. PubMed ID: 37832554
[TBL] [Abstract][Full Text] [Related]
27. Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy.
Mori T; Kumagai K; Nasu K; Yoshizawa T; Kuwano K; Hamada Y; Kanazawa H; Suzuki R
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499345
[TBL] [Abstract][Full Text] [Related]
28. Dissecting T-cell heterogeneity in esophageal squamous cell carcinoma reveals the potential role of LAIR2 in antitumor immunity.
Wang P; Zhuang W; Zheng Z; Zhang L; Zhang X; Chen Q
Clin Exp Immunol; 2023 Dec; 214(1):36-49. PubMed ID: 37422711
[TBL] [Abstract][Full Text] [Related]
29. CD177 drives the transendothelial migration of Treg cells enriched in human colorectal cancer.
Ke S; Lei Y; Guo Y; Xie F; Yu Y; Geng H; Zhong Y; Xu D; Liu X; Yu F; Xia X; Zhang Z; Zhu C; Ling W; Li B; Zhao W
Clin Transl Immunology; 2024; 13(4):e1506. PubMed ID: 38596253
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma.
Koga N; Hu Q; Sakai A; Takada K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Oki E; Oda Y; Mori M
Cancer Sci; 2021 Aug; 112(8):3018-3028. PubMed ID: 34009732
[TBL] [Abstract][Full Text] [Related]
31. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
[TBL] [Abstract][Full Text] [Related]
32. Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.
Takehara Y; Tamaki T; Mimura K; Saito K; Neupane P; Tada T; Watanabe Y; Hayase S; Saze Z; Yoshimoto Y; Sato H; Kono K; Suzuki Y
Anticancer Res; 2023 Oct; 43(10):4691-4700. PubMed ID: 37772585
[TBL] [Abstract][Full Text] [Related]
33. GITR agonistic stimulation enhances the anti-tumor immune response in a mouse model of ESCC.
Wiles KN; Tsikretsis LE; Alioto CM; Hermida de Viveiros PA; Villaflor VM; Tétreault MP
Carcinogenesis; 2022 Oct; 43(9):908-918. PubMed ID: 35880612
[TBL] [Abstract][Full Text] [Related]
34. [The Development of Combinatorial Cancer Immunotherapy with Anti-PD-1 Therapy and Radiotherapy for Patients with Esophageal Squamous Cell Carcinoma].
Mimura K; Kono K
Gan To Kagaku Ryoho; 2022 Sep; 49(9):914-916. PubMed ID: 36156004
[TBL] [Abstract][Full Text] [Related]
35. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
[TBL] [Abstract][Full Text] [Related]
36. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.
Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y
Front Immunol; 2023; 14():1117658. PubMed ID: 36817484
[TBL] [Abstract][Full Text] [Related]
37. Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis.
Xiao Z; Yan R; Liu H; Huang X; Liang Z; An G; Ge Y
Cancer Prev Res (Phila); 2023 Dec; 16(12):669-679. PubMed ID: 37857481
[TBL] [Abstract][Full Text] [Related]
38. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
40. Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
